Researchers analyzed 73 decision aids for breast, cervical, colon and prostate cancers. Less than half had been promoted for use with subsequent screening behavior, and only 18 were found to be used for shared decision making.
“Our goal was to determine whether decision aids could potentially lead to better shared decision-making regarding screening between the patient and the clinician. There is evidence that decision aids are fairly effective in improving patient knowledge but we found that they may not be used as well and effectively as they could be,” said lead author Masahito Jimbo, MD, PhD, associate professor in family medicine and urology at the University of Michigan Medical School in a news release.
More Articles on Oncology Quality:
Study: Medication Error Rate Among Pediatric Cancer Patients Higher at Home Than in Hospital
The Oncology Service Line in the Coming Year: 4 Developments
FDA Issues Warning on Potential Breast Cancer Drug Mix-Up
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
